Neuro-Oncology Reviews




Volume 22 Number 6
31 March 2020




Home > Publications > Neuro-Oncology Reviews > Volume 22, Year 2020 > Number 6, 31 March






Cohen KJ et al, PDQ Pediatric Treatment Editorial Board.
Childhood Brain and Spinal Cord Tumors Treatment Overview (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 Mar 17
. NCBI Bookshelf ID: NBK66018. PMID: 26389453. Review. ˍ




Han Q, Liang H, Cheng P, Yang H, Zhao P.
Gross Total vs. Subtotal Resection on Survival Outcomes in Elderly Patients With High-Grade Glioma: A Systematic Review and Meta-Analysis.
Front Oncol. 2020 Mar 18. 2020;10:151. doi: 10.3389/fonc.2020.00151. PMID: 32257941. Review, Meta-analysis. ˍ




Cohen KJ, et al, PDQ Pediatric Treatment Editorial Board.
Childhood Ependymoma Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 Mar 20. NCBI Bookshelf ID: NBK65935. PMID: 26389373. Review. ˍ




Cohen KJ et al, PDQ Pediatric Treatment Editorial Board.
Childhood Craniopharyngioma Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 Mar 20. NCBI Bookshelf ID: NBK65891. PMID: 26389330. Review. ˍ




Dong Z, Cui H.
The Emerging Roles of RNA Modifications in Glioblastoma.
Cancers (Basel). 2020 Mar 20;12(3):736. doi: 10.3390/cancers12030736. PMID: 32244981. Review. ˍ




Norouzi M.
Gold Nanoparticles in Glioma Theranostics.
Pharmacol Res. 2020 Mar 21;156:104753. doi: 10.1016/j.phrs.2020.104753. PMID: 32209363. Review. ˍ




Weenink B, French PJ, Sillevis Smitt PAE, Debets R, Geurts M.
Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives.
Cancers (Basel). 2020 Mar 22;12(3):751. doi: 10.3390/cancers12030751. PMID: 32235752. Review. ˍ




Cohen KJ et al., PDQ Pediatric Treatment Editorial Board.
Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 Mar 23. NCBI Bookshelf ID: NBK65981. PMID: 26389418. Review. ˍ




Lv L, Huang J, Xi H, Zhou X.
Efficacy and safety of dendritic cell vaccines for patients with glioblastoma: A meta-analysis of randomized controlled trials.
Int Immunopharmacol. 2020 Mar 23;83:106336. doi: 10.1016/j.intimp.2020.106336. PMID: 32213460. Meta-analysis. ˍ




Tajima Y, Takahashi M, Kawai T, Higashi M, Sano H, Ichimura S, Kobayashi H.
Metastatic intradural extramedullary spinal cord tumor from ovarian cancer: A case report with a literature review.
J Spinal Cord Med. 2020 Mar 23, 2022;45(2):320-323. doi: 10.1080/10790268.2020.1739380. PMID: 32202486. Case report, Review. ˍ




Werner JM, Lohmann P, Fink GR, Langen KJ, Galldiks N.
Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors.
Molecules. 2020 Mar 24;25(6):E1471. doi: 10.3390/molecules25061471. PMID: 32213992. Review. ˍ




Silvia N, Dai G.
Cerebral organoids as a model for glioblastoma multiforme.
Curr Opin Biomed Eng. 2020 Mar 25;13:152-159. doi: 10.1016/j.cobme.2020.03.004. PMID: 32355905. Review. ˍ




Yamamoto J, Kitagawa T, Miyaoka R, Suzuki K, Takamatsu S, Saito T, Nakano Y.
5-Aminolevulinic Acid: Pitfalls of Fluorescence-guided Resection for Malignant Gliomas and Application for Malignant Glioma Therapy.
J UOEH. 2020 Mar 25;42(1):27-34. doi: 10.7888/juoeh.42.27. PMID: 32213740. Review. ˍ




Garcia J, Hurwitz HI, Sandler AB, Miles D, Coleman RL, Deurloo R, Chinot OL.
Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook.
Cancer Treat Rev. 2020 Mar 26;86:102017. doi: 10.1016/j.ctrv.2020.102017. PMID: 32335505. Review. ˍ




Le Rhun E, Seoane J, Salzet M, Soffietti R, Weller M.
Liquid biopsies for diagnosing and monitoring primary tumors of the central nervous system.
Cancer Lett. 2020 Mar 27;480:24-28. doi: 10.1016/j.canlet.2020.03.021. PMID: 32229189. Review. ˍ




Mallereau CH, Ganau M, Todeschi J, Cebula H, Santin MD, Virbel G, Pop R, Lhermitte B, Proust F, Chibbaro S.
Primary Brain Rhabdomyosarcoma Causing Extracranial Metastases: Case Report with Narrative Review of Atypical Presentations and Their Diagnostic Challenges.
World Neurosurg. 2020 Mar 27;138:363‐368. doi: 10.1016/j.wneu.2020.03.110. PMID: 32229305. Case report, Review. ˍ




Upadhaya PG, Pulakkat S, Patravale VB.
Nose-to-brain delivery: exploring newer domains for glioblastoma multiforme management.
Drug Deliv Transl Res. 2020 Mar 27. doi: 10.1007/s13346-020-00747-y. PMID: 32221847. Review. ˍ




Delgado-López PD, Saiz-López P, Gargini R, Sola-Vendrell E, Tejada S.
A comprehensive overview on the molecular biology of human glioma: what the clinician needs to know.
Clin Transl Oncol. 2020 Mar 28. doi: 10.1007/s12094-020-02340-8. PMID: 32222898. Review. ˍ




Alexandru O, Horescu C, Sevastre AS, Cioc CE, Baloi C, Oprita A, Dricu A.
Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches.
Contemp Oncol (Pozn). 2020 Mar 30;24(1):55-66. doi: 10.5114/wo.2020.94726. PMID: 32514239. Review. ˍ




Tjota MY, Pytel P.
Educational Case: Pilocytic Astrocytoma With Atypical Features.
Acad Pathol. 2020 Mar 30;7:2374289520912498. doi: 10.1177/2374289520912498. PMID: 32284965. Case report, Educational. ˍ




Rogers LR, Ostrom QT, Schroer J, Vengoechea J, Li L, Gerson S, Nock CJ, Machtay M, Selman W, Lo S, Sloan AE, Barnholtz-Sloan JS.
Association of metabolic syndrome with glioblastoma: a retrospective cohort study and review.
Neurooncol Pract. 2020 Mar 31;7(5):541-548
. doi: 10.1093/nop/npaa011. PMID: 33014395. Observational study, Review. ˍ




Wu G, Song X, Liu J, Li S, Gao W, Qiu M, Yang C, Ma Y, Chen Y.
Expression of CD44 and the survival in glioma: a meta-analysis.
Biosci Rep. 2020 Mar 31;40(4):BSR20200520. doi: 10.1042/BSR20200520. PMID: 32232385. Meta-analysis. ˍ




Yao L, Alahmari M, Temel Y, Hovinga K.
Therapy of Sporadic and NF2-Related Vestibular Schwannoma.
Cancers (Basel). 2020 Mar 31;12(4):E835. doi: 10.3390/cancers12040835. PMID: 32244314. Review. ˍ